December 19, 2020
3 min watch
Save
VIDEO: IBD therapies not linked with adverse pregnancy outcomes
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this exclusive video, Uma Mahadevan, MD, from the University of California, San Francisco, discusses the results of the PIANIO Study, which explores outcomes of pregnant women with inflammatory bowel disease and their children.
She said they found no association between biologic, thiopurine or combination therapy and adverse outcomes at birth or within the first year of life. Additionally, she said physicians should continue providing IBD medication throughout pregnancy.
Published by:
Sources/Disclosures
Collapse
Source:
Mahadevan U. “Hot Topics in Pregnancy and IBD: The PIANO Study.” Presented at: Advances in Inflammatory Bowel Diseases. Dec. 9-12, 2020.
Disclosures:
Mahadevan reports consulting for AbbVie, Janssen, Pfizer and Takeda and receiving a research grant from Pfizer.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.